Skip to main content
TipRanks
Go Ultimate75% OFF

IRLAB Therapeutics AB Class A (6IRA) Balance Sheet

1 Followers

IRLAB Therapeutics AB Class A Balance Sheet

IRLAB Therapeutics AB Class A's total assets for Q3 2026 were kr153.86M, a decrease of 15.63% from the previous quarter. DE:6IRA total liabilities were kr73.70M for the fiscal quarter, a 13.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
kr 138.21Mkr 136.21Mkr 177.12Mkr 323.56Mkr 472.45M
kr 107.49Mkr 103.58Mkr 61.36Mkr 32.72Mkr 72.97M
kr 30.72Mkr 32.63Mkr 115.76Mkr 290.83Mkr 399.48M

Currency in SEK

IRLAB Therapeutics AB Class A Liabilities to Assets

0200M400M600M0 %30 %60 %90 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets